Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Thyssensche Handelsgesellschaft (THG) is a private German investment holding company and family office that manages the assets of a branch of the Thyssen family. The firm specializes in long-term equity investments in established medium-sized companies, particularly in the healthcare, specialty chemicals, and industrial sectors. A cornerstone of its healthcare portfolio is its significant stake in Schülke & Mayr, a global leader in infection prevention and hygiene solutions. THG provides strategic guidance and capital to its subsidiaries to foster sustainable growth and market leadership. Headquartered in Mülheim an der Ruhr, the company operates with a permanent capital base, allowing for a multi-generational investment horizon.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Thyssensche Handelsgesellschaft.